News About: Pharm. Industry
60 2nd & 3rd generations running pharmaceutical companies
While 2nd and 3rd generations have actively operated pharmaceutical companies, there were 60 owner-family executives born in later than 1960. Particularly, 13 2nd, 3rd and 4th generations of the owner family were prom...
Humedix recruits CEO Goo-Wan Jung, former CEO of Allergan and Alcon Korea
Huons Global announced the company recruited Goo-Wan Jung, who used to be a CEO at Allergan Korea and Alcon Korea, as a CEO of Humedix on the 9th.
CEO Goo-Wan Jung, a graduate of Sogang University majoring in busines...
Hanmi Pharm Group’s active overseas expansion of integrated logistics service
Hanmi Pharm Group will actively start to expand the general logistics business, particularly related to the medical device field, to foreign markets.
On the 9th, Hanmi IT(CEO Jong-Hoon Lim), a subsidiary of Hanmi Pha...
Pfizer Pharmaceuticals Korea’s ‘Xalkori’ extended in insurance benefit from this January
Pfizer Pharmaceuticals Korea(CEO/President Dong-Wook Oh) announced its targeted therapy for lung cancer, ‘Xalkori(generic name: crizotinib),’ will be applied by the health insurance benefit as a primary treatment of a...
Will imprisonment of director of pharmaceutical company impact the industry?
As a director of the pharmaceutical company Y was sentenced to imprisonment even at an appeal on the 6th, the pharmaceutical industry has been tense.
In consideration of the fact it is the first case for a director o...
Director of pharmaceutical company Y sentenced to imprisonment at appeal
A director of a medium-sized pharmaceutical company Y, who was sentenced to imprisonment for provision of rebates to doctors, was sentenced to imprisonment again at the appeal.
According to industry concerned, the Se...
Beijing Hanmi Pharm enters world’s largest pharmaceutical automation market with JVM
Beijing Hanmi Pharm(CEO Hye-Ryong Lim), a Chinses branch of Hanmi Pharm Group, will enter the medicine control and manufacturing automation system market through its affiliate, JVM.
Thus, Beijing Hanmi Pharm will sup...
FTC focus on monitoring pharmas ‘reverse payment agreement’
The Fair Trade Commission(FTC) showed the 2017 business plan and announced to focus on pharmaceutical companies’ reverse payment agreements.
The FTC criticized the pharmaceutical field’s enforcement(March 15 2015) of...
Ildong Pharmaceutical challenges to KRW 100 billion market of fillerIldong Pharmaceutical(CEO Woong-Sup Yoon) released ‘Neobelle,’ hyaluronic acid filler for wrinkle improvement, and has started to pioneer its market. Based on the original techn...
|
Chong Kun Dang received highest grade AA on 2016 CP Grade EvaluationChong Kun Dang(CEO Young-Joo Kim) announced the company received the highest grade, ‘AA,’ on the ‘2016 Fair Trade Compliance Program’ managed by the Fair Trade Commission among ...
|
